查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1613162

避孕药具市场：依产品、年龄层、药物类别、处方形式、分布、给药途径 - 2025-2030 年全球预测

Contraceptive Pills Market by Product (Combination Pill, Continuous/Extended Pill, Progesterone Pill), Age Group (15-24, 25-34, 35-44), Drug Class, Mode of Prescription, Distribution, Route of Administration - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年避孕药具市场价值为195.3亿美元，预计到2024年将达到207.6亿美元，复合年增长率为6.46%，到2030年将达到302.7亿美元。

避孕药市场的定义是透过抑制排卵的荷尔蒙製剂来预防怀孕。口服避孕药有多种类型，包括雌激素和黄体素复方口服避孕药和纯黄体素药丸，它们主要针对育龄妇女。避孕药具的需求源于人们对计划生育意识的提高、对有效预防怀孕方法的需求以及赋予妇女做出生育选择的权力。这些药物不仅可用于避孕，还可用于治疗月经失调、痤疮和子宫内膜异位症，从而将最终用途范围扩大到不同的人。教育水准的提高、医疗保健机会的增加以及政府对避孕措施支持的增加对市场成长产生了重大影响。低剂量药物的最新进展和长週期药物的推出为市场扩张提供了潜在的机会。为了利用这些机会，公司应专注于提高负担能力、扩大分销管道并透过教育宣传活动提高意识。然而，副作用风险、道德和宗教反对以及监管限制等挑战可能会阻碍市场扩张。此外，由于文化偏见和缺乏意识，一些地区的市场渗透率有限。该领域的创新已经成熟，可以开发非荷尔蒙药丸、个人化医疗方法以及用于改善和追踪药物依从性的数位健康解决方案。这些创新以及与医疗保健提供者的策略伙伴关係关係可以推动业务成长。该市场呈现出分散但动态的特点，并具有透过併购进行整合的潜力。总体而言，响应不断变化的需求和观念、投资研发并专注于个人化体验对于在这个竞争激烈但前景光明的市场中获得成长至关重要。

主要市场统计
基准年[2023] 195.3亿美元
预测年份 [2024] 207.6亿美元
预测年份 [2030] 302.7亿美元
复合年增长率（%） 6.46%

市场动态：揭示快速发展的避孕市场的关键市场洞察

供需的动态交互作用正在改变避孕药具市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 增加避孕药具的使用以防止意外怀孕并提高计划生育意识
    • 性行为感染传染病（STD）盛行率上升
    • 政府鼓励避孕措施的支持措施
  • 市场限制因素
    • 因避孕药具和不良健康影响而发生产品召回
  • 市场机会
    • 避孕药配方和包装的进展
    • 透过线上管道提供避孕药具
  • 市场挑战
    • 有关药丸使用和产品行销问题的安全和社会问题

波特五力：驾驭避孕市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解避孕药市场的外部影响

外部宏观环境因素对避孕药具市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解避孕药具市场的竞争格局

对避孕药市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵避孕药具市场供应商绩效评估

FPNV定位矩阵是评估避孕药具市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和推荐的避孕药市场，以规划成功之路

避孕药市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加使用避孕药来防止意外怀孕并提高计划生育意识
      • 性行为感染传染病（STD）盛行率增加
      • 政府支持措施促进避孕药具的使用
    • 抑制因素
      • 避孕产品召回与不良健康影响的发生
    • 机会
      • 避孕药配方和包装的不断进步
      • 透过线上管道提供避孕药具
    • 任务
      • 有关锭剂使用和产品行销问题的安全和社会问题
  • 市场区隔分析
    • 产品：广泛的适用性和额外的健康益处增加了组合药物的采用
    • 给药途径：口服避孕药的广泛接受性、可用性和成本效益
    • 年龄层：15至24岁年龄层的避孕药使用率较高。
    • 配送：避孕药具线上配送管道的演变
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 避孕药市场：副产品

  • 组合药丸
  • 延续/延长药丸
  • 黄体酮丸

第七章 避孕药市场：依年龄组别

  • 15-24
  • 25-34
  • 35-44
  • 45岁以上

第八章以药物类别分類的避孕药市场

  • 品牌药品
  • 学名药

第九章以处方方式分類的避孕药市场

  • 贴片机上 (OTC)
  • 根据处方笺

第十章 避孕药具市场经销商

  • 离线
    • 诊所和医院
    • 药局
    • 公共卫生机构
  • 在线的

第十一章 避孕药市场：依给药途径

  • 口服
  • 阴道

第十二章美洲避孕市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十三章亚太避孕市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十四章 欧洲、中东和非洲避孕市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Perrigo 在美国推出首款非处方每日避孕药，旨在扩大生殖保健服务的可近性和可负担性。
    • 英国已开始试验无激素男性避孕药 YCT-529，目标是在 2020 年获得监管部门核准并进入市场。 2024年
    • Richter 和 Misra 签署复方口服避孕药 Ester 和 Donesta 的 API 生产和供应协议
    • FDA核准首个非处方笺口服避孕药
    • Gedeon Richter 宣布推出口服避孕药 Droberis
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Afaxys Pharma, LLC
  • Amneal Pharmaceuticals, Inc.
  • Apotex Inc.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Bionpharma Inc.
  • Cipla Limited
  • Combe Incorporated
  • Gedeon Richter PLC
  • Glenmark Pharmaceuticals Limited
  • Johnson & Johnson Services, Inc.
  • Julie Product Inc.
  • Lupin Limited
  • Mankind Pharma Ltd.
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Northstar Rx LLC
  • Perrigo Company plc
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Sun Pharmaceutical Industries Limited
  • Syzygy Healthcare Solutions, LLC
  • Teva Pharmaceuticals
  • Viatris Inc.
  • Xiromed, LLC
Product Code: MRR-A579C4315A23

The Contraceptive Pills Market was valued at USD 19.53 billion in 2023, expected to reach USD 20.76 billion in 2024, and is projected to grow at a CAGR of 6.46%, to USD 30.27 billion by 2030.

The contraceptive pills market is defined by its role in preventing pregnancy through hormonal formulations that inhibit ovulation. It encompasses various types, including combined oral contraceptives (estrogen and progestin) and progestin-only pills, catering primarily to women in reproductive age groups. The necessity of contraceptive pills stems from the increasing awareness of family planning, the need for effective pregnancy prevention methods, and the empowerment of women in making reproductive choices. These pills find applications not only in contraception but also in managing menstrual disorders, acne, and endometriosis, extending their end-use scope across diverse demographics. Market growth is heavily influenced by rising educational levels, increasing access to healthcare, and growing governmental support for birth control measures. Recent advancements in lower dosage pills and the introduction of extended-cycle pills present potential opportunities for market expansion. To tap into these opportunities, companies should focus on enhancing affordability, expanding distribution channels, and raising awareness through education campaigns. However, challenges such as the perceived risk of side effects, ethical and religious opposition, and regulatory restrictions could impede market expansion. Additionally, market penetration is limited in some regions due to cultural biases and lack of awareness. Innovations in the field are ripe in the areas of developing non-hormonal pills, personalized medicine approaches, and digital health solutions for better medication adherence and tracking. These innovations, alongside strategic partnerships with healthcare providers, can drive business growth. The market exhibits a dynamic, albeit fragmented nature, indicating potential consolidation through mergers and acquisitions. Overall, staying attuned to evolving needs and perceptions, investing in R&D, and focusing on personalized experiences will be crucial for capturing growth in this competitive yet promising market.

KEY MARKET STATISTICS
Base Year [2023] USD 19.53 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 30.27 billion
CAGR (%) 6.46%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Contraceptive Pills Market

The Contraceptive Pills Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use of contraceptive pills to prevent unintended pregnancies and rising awareness about family planning
    • Growing prevalence of sexually transmitted diseases (STDs)
    • Supportive government initiatives to encourage use of contraceptive pills
  • Market Restraints
    • Incidences of product recalls & adverse health impacts of contraceptive pills
  • Market Opportunities
    • Ongoing advancements in contraceptive pill formulations and packaging
    • Availability of contraceptive pills through online channels
  • Market Challenges
    • Safety and social concerns regarding pill usage and issues with product marketing

Porter's Five Forces: A Strategic Tool for Navigating the Contraceptive Pills Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Contraceptive Pills Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Contraceptive Pills Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Contraceptive Pills Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Contraceptive Pills Market

A detailed market share analysis in the Contraceptive Pills Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Contraceptive Pills Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Contraceptive Pills Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Contraceptive Pills Market

A strategic analysis of the Contraceptive Pills Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Contraceptive Pills Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Afaxys Pharma, LLC, Amneal Pharmaceuticals, Inc., Apotex Inc., Aurobindo Pharma Limited, Bayer AG, Bionpharma Inc., Cipla Limited, Combe Incorporated, Gedeon Richter PLC, Glenmark Pharmaceuticals Limited, Johnson & Johnson Services, Inc., Julie Product Inc., Lupin Limited, Mankind Pharma Ltd., Mayne Pharma Group Limited, Merck & Co., Inc., Northstar Rx LLC, Perrigo Company plc, Pfizer Inc., Piramal Enterprises Ltd., Sun Pharmaceutical Industries Limited, Syzygy Healthcare Solutions, LLC, Teva Pharmaceuticals, Viatris Inc., and Xiromed, LLC.

Market Segmentation & Coverage

This research report categorizes the Contraceptive Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Combination Pill, Continuous/Extended Pill, and Progesterone Pill.
  • Based on Age Group, market is studied across 15-24, 25-34, 35-44, and 45 and Above.
  • Based on Drug Class, market is studied across Branded Drugs and Generic Drugs.
  • Based on Mode of Prescription, market is studied across Over-the-Mounter (OTC) and Prescription-Based.
  • Based on Distribution, market is studied across Offline and Online. The Offline is further studied across Clinics and Hospitals, Pharmacies, and Public Health Organizations.
  • Based on Route of Administration, market is studied across Oral and Viginal.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use of contraceptive pills to prevent unintended pregnancies and rising awareness about family planning
      • 5.1.1.2. Growing prevalence of sexually transmitted diseases (STDs)
      • 5.1.1.3. Supportive government initiatives to encourage use of contraceptive pills
    • 5.1.2. Restraints
      • 5.1.2.1. Incidences of product recalls & adverse health impacts of contraceptive pills
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in contraceptive pill formulations and packaging
      • 5.1.3.2. Availability of contraceptive pills through online channels
    • 5.1.4. Challenges
      • 5.1.4.1. Safety and social concerns regarding pill usage and issues with product marketing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging adoption of combination pills owing to their broad applicability and additional health benefits
    • 5.2.2. Route of Administration: Widespread acceptance, ease of access, and cost-effectiveness of oral contraceptives
    • 5.2.3. Age Group: High usage of contraceptive pills in the age group 15 to 24
    • 5.2.4. Distribution: Evolving online distribution channels for contraceptive pills
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Contraceptive Pills Market, by Product

  • 6.1. Introduction
  • 6.2. Combination Pill
  • 6.3. Continuous/Extended Pill
  • 6.4. Progesterone Pill

7. Contraceptive Pills Market, by Age Group

  • 7.1. Introduction
  • 7.2. 15-24
  • 7.3. 25-34
  • 7.4. 35-44
  • 7.5. 45 and Above

8. Contraceptive Pills Market, by Drug Class

  • 8.1. Introduction
  • 8.2. Branded Drugs
  • 8.3. Generic Drugs

9. Contraceptive Pills Market, by Mode of Prescription

  • 9.1. Introduction
  • 9.2. Over-the-Mounter (OTC)
  • 9.3. Prescription-Based

10. Contraceptive Pills Market, by Distribution

  • 10.1. Introduction
  • 10.2. Offline
    • 10.2.1. Clinics and Hospitals
    • 10.2.2. Pharmacies
    • 10.2.3. Public Health Organizations
  • 10.3. Online

11. Contraceptive Pills Market, by Route of Administration

  • 11.1. Introduction
  • 11.2. Oral
  • 11.3. Viginal

12. Americas Contraceptive Pills Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Contraceptive Pills Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Contraceptive Pills Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Perrigo launched the First OTC daily birth control pill in the U.S., aiming to expand reproductive health access and affordability.
    • 15.3.2. UK launched trial for hormone-free male birth control YCT-529 aiming for regulatory approval and market entry by 2024
    • 15.3.3. Richter and Mithra sign supply agreement for production of API for combined oral contraceptive Estelle and Donesta
    • 15.3.4. FDA approves first nonprescription daily oral contraceptive
    • 15.3.5. Gedeon Richter announces availability of oral contraception Drovelis
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Afaxys Pharma, LLC
  • 3. Amneal Pharmaceuticals, Inc.
  • 4. Apotex Inc.
  • 5. Aurobindo Pharma Limited
  • 6. Bayer AG
  • 7. Bionpharma Inc.
  • 8. Cipla Limited
  • 9. Combe Incorporated
  • 10. Gedeon Richter PLC
  • 11. Glenmark Pharmaceuticals Limited
  • 12. Johnson & Johnson Services, Inc.
  • 13. Julie Product Inc.
  • 14. Lupin Limited
  • 15. Mankind Pharma Ltd.
  • 16. Mayne Pharma Group Limited
  • 17. Merck & Co., Inc.
  • 18. Northstar Rx LLC
  • 19. Perrigo Company plc
  • 20. Pfizer Inc.
  • 21. Piramal Enterprises Ltd.
  • 22. Sun Pharmaceutical Industries Limited
  • 23. Syzygy Healthcare Solutions, LLC
  • 24. Teva Pharmaceuticals
  • 25. Viatris Inc.
  • 26. Xiromed, LLC

LIST OF FIGURES

  • FIGURE 1. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACEPTIVE PILLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTRACEPTIVE PILLS MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CONTINUOUS/EXTENDED PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTERONE PILL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 15-24, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 25-34, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 35-44, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 45 AND ABOVE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OVER-THE-MOUNTER (OTC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINICS AND HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PUBLIC HEALTH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY VIGINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 310. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 311. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY MODE OF PRESCRIPTION, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 323. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 324. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2023